Global Expression Vector Market: Industry Analysis and Forecast (2019-2027) by Type, End-User, and Region

Global Expression Vector Market size was valued at US$ 315.10 Mn in 2019 and the total revenue is expected to grow at 5.5% through 2019 to 2027, reaching nearly US$ 483.58Mn in the forecast period.

Global Expression Vector Market Overview:

An expression vector is a plasmid used in the production of insulin in the human body to treat a disease like diabetes. The feature of the expression vector is the origin of replication, a selectable marker, and a suitable site for the insertion of the gene for multiple cloning sites. Hence, an expression vector is a plasmid engineered to introduce a particular gene into target cells. Global Expression Vector Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2026. 2019 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Global Expression Vector Market Dynamics:

The global expression market is growing at a high pace in the forecast period. The growth of the market is attributed to the demand for protein-based drugs. As protein-based drugs are genetically modified versions of human protein to achieve maximum therapeutic output. The high occurrence of chronic diseases and proliferation of genetic diseases is likely to boost the growth of the expression vector market. The development and introduction of the latest biotechnologies in the field of genetics, protein modification, bioinformatics, and molecular biology are the key factors for the growth of the market. Besides, the demand for medical necessities due to the patent expiration of generic drugs in the market is likely to drive the market growth. In addition, growing mergers and collaborations of pharmaceutical industries are likely to fuel the market expansion and hence leading the market growth. For instance, QIAGEN fully acquires the remaining 80% of the market share of NeuMoDx molecular, Inc. a diagnostic instrument company for PCR-based diagnostic automation systems. As a result, the company is building a position in automated molecular testing. The application of expression vector in human insulin production and R&D of biomedical and biopharmaceutical ingredients and products is anticipated to hit the market growth in the forecast period.

Global Expression Vector Market Segment Analysis:

More than 1L segment is dominating the Type segment of Global Expression Vector Market: The Bacterial vector segment is dominating the type segment of the global expression vector market. The growth of the segment is attributed to a high transformation level and simple transformation protocol. Bacterial vector is an element of the RABV Antigen Delivery System. As bacterial vectors are useful in transporting genetic information into the eukaryotic cells. Due to various innovations and technological development, the applications of bacterial vectors several bacterial vectors have been used for vaccines like HIV vaccines. The mammalian expression vector segment is estimated to grow at a high pace in the expression vector market. The growth of the segment is attributed to the ability of the mammalian vector system to carry out recombinant protein, folding, and post-translational innovations. The Pharmaceutical Industry segment is considered to supplement the growth of the Global Expression Vector Market. Pharmaceutical and biotechnology companies dominated the end-user segment of the Expression vector market with 19.8% of market share and are expected to grow at a high pace during the forecast period. Further, the investment by the pharmaceutical companies in R&D for gene therapies and expression vector applications is likely to lift the growth of the market. In 2019, research and development spending in the pharmaceutical industry was around 186 billion in USD globally. The pharmaceutical and biotechnology sector is more driven by the imperative to manufacturing innovative products and results in spending a significant amount in R&D. Time-limited patent protection of drugs is hitting the market to gear up with the research activities. Hence this factor is likely to boost the growth of the expression vector market. Besides, protein synthesis in the pharmaceutical industry by aiding recombinant DNA technology is a key factor in the expansion of the market. Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) segment is estimated to grow with significant market share. CROs service is projected to reach USD 86.6 billion by 2027 with a CAGR of 10.7%. Growth in drug and biologics, despite COVID-19, is likely to create more opportunities for the segment. Global Expression Vector Market

Global Expression Vector Market Regional Insights:

Global Expression Vector Market Regional Insights is segmented into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa. North America is leading in the Expression Vector Market with 42.7% of market share in 2020 due to the presence of a major market player like Agilent Technologies. The growth of the region is attributed to wider exposure to technologies and advancement in the research and development sector with high-tech infrastructure. Moreover, mergers and acquisitions are playing an important role in the expression vector market. For example, In September, Agilent Technologies acquire ACEA Bioscience for USD 250 million to increase the presence of the company in cell analysis technologies. Further, In August 2019, Agilent acquired US-based BioTeck Instrument, a nationwide leader of design, manufacturing, and distribution of innovative life science instrumentation for USD 1.165 billion. These mergers and acquisitions are likely to motivate the growth of the market due to the forecast period. Asia Pacific is gaining a significant market share with the highest CAGR of 7.3% during the forecast period. In addition, biotechnology and pharmaceutical companies are driving the growth of the market. Further, the growth of the region is also driven by amplified biotechnological activities with the help of private or government research organizations. Besides growing awareness among the individuals is likely to lift the market expansion. Global Expression Vector Market The objective of the report is to present a comprehensive analysis of the Global Expression Vector Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Expression Vector Market dynamics, structure by analyzing the market segments and project the Global Expression Vector Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Expression Vector Market make the report investor’s guide.

Global Expression Vector Market Scope: Inquire before buying

Global Expression Vector Market

Global Expression Vector Market, by Region

• North America o The U.S. o Canada • Europe o Germany o The U.K. o France o Italy o Spain • Asia Pacific o Japan o China o India o Australia o South Korea • Latin America o Brazil o Mexico o Argentina o Colombia • The Middle East and Africa (MEA) o South Africa o Saudi Arabia o UAE

Global Expression Vector Market Key Player

Agilent Technologies, Inc. Thermo Fisher Scientific Inc. • Promega Corporation • Bio-Rad Laboratories • Merck Millipore • QIAGEN • Clontech Laboratories, Inc. • DNA2.0 • New England Biolabs • Sigma-Aldrich Corporation • GenScript USA Inc • GENERAL ELECTRIC

FAQs:

1. What is the global Expression Vector Market share in 2019? Ans: Approximately, 315.10 Million USD. 2. What is the global Expression Vector Market growth? Ans: The global Expression Vector Market is anticipated to grow with a CAGR of 5.5% in the forecast period and is likely to reach USD 483.58 million by the end of 2027. 3. Which End-User segment is expected to dominate the global Expression Vector Market during the forecast period? Ans: The Hospital segment dominated the market with a share of over 38.4% in 2020 and is expected to exhibit the highest CAGR during the forecast period. 4. Which region is expected to dominate the global Expression Vector Market during the forecast period? Ans: North America dominated the Expression Vector Market with a share of over 42.7% in 2020 owing to the larger exposure of research and development activities in the region by biopharmaceutical companies. 5. Who are the key players in the global Expression Vector Market? Ans: Key players of the market include Agilent Technologies, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck Millipore, QIAGEN, Clontech Laboratories, Inc., DNA2.0, New England Biolabs, Sigma-Aldrich Corporation, and GenScript USA Inc
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Expression Vector Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Expression Vector Market 3.4. Geographical Snapshot of the Expression Vector Market, By Manufacturer share 4. Global Expression Vector Market Overview, 2019-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Expression Vector Market 5. Supply Side and Demand Side Indicators 6. Global Expression Vector Market Analysis and Forecast, 2019-2027 6.1. Global Expression Vector Market Size & Y-o-Y Growth Analysis. 7. Global Expression Vector Market Analysis and Forecasts, 2019-2027 7.1. Market Size (Value) Estimates & Forecast By Type, 2019-2027 7.1.1. Bacterial/E.Coli 7.1.2. Mammalian/CHO 7.1.3. Insect/Baculovirus 7.1.4. Yeast 7.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 7.2.1. Pharmaceutical and Biotechnology Companies 7.2.2. Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) 7.2.3. Academic Research Institutes 8. Global Expression Vector Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Expression Vector Market Analysis and Forecasts, 2019-2027 9.1. Market Size (Value) Estimates & Forecast By Type, 2019-2027 9.1.1. Bacterial/E.Coli 9.1.2. Mammalian/CHO 9.1.3. Insect/Baculovirus 9.1.4. Yeast 9.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 9.2.1. Pharmaceutical and Biotechnology Companies 9.2.2. Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos) 9.2.3. Academic Research Institutes 10. North America Expression Vector Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Expression Vector Market Analysis and Forecasts, 2019-2027 11.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 11.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 12. Canada Expression Vector Market Analysis and Forecasts, 2019-2027 12.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 12.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 13. Mexico Expression Vector Market Analysis and Forecasts, 2019-2027 13.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 13.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 14. Europe Expression Vector Market Analysis and Forecasts, 2019-2027 14.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 14.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 15. Europe Expression Vector Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Expression Vector Market Analysis and Forecasts, 2019-2027 16.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 16.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 17. France Expression Vector Market Analysis and Forecasts, 2019-2027 17.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 17.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 18. Germany Expression Vector Market Analysis and Forecasts, 2019-2027 18.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 18.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 19. Italy Expression Vector Market Analysis and Forecasts, 2019-2027 19.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 19.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 20. Spain Expression Vector Market Analysis and Forecasts, 2019-2027 20.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 20.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 21. Sweden Expression Vector Market Analysis and Forecasts, 2019-2027 21.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 21.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 22. CIS Countries Expression Vector Market Analysis and Forecasts, 2019-2027 22.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 22.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 23. Rest of Europe Expression Vector Market Analysis and Forecasts, 2019-2027 23.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 23.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 24. Asia Pacific Expression Vector Market Analysis and Forecasts, 2019-2027 24.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 24.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 25. Asia Pacific Expression Vector Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Expression Vector Market Analysis and Forecasts, 2019-2027 26.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 26.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 27. India Expression Vector Market Analysis and Forecasts, 2019-2027 27.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 27.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 28. Japan Expression Vector Market Analysis and Forecasts, 2019-2027 28.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 28.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 29. South Korea Expression Vector Market Analysis and Forecasts, 2019-2027 29.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 29.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 30. Australia Expression Vector Market Analysis and Forecasts, 2019-2027 30.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 30.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 31. ASEAN Expression Vector Market Analysis and Forecasts, 2019-2027 31.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 31.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 32. Rest of Asia Pacific Expression Vector Market Analysis and Forecasts, 2019-2027 32.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 32.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 33. Middle East Africa Expression Vector Market Analysis and Forecasts, 2019-2027 33.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 33.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 34. Middle East Africa Expression Vector Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Expression Vector Market Analysis and Forecasts, 2019-2027 35.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 35.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 36. GCC Countries Expression Vector Market Analysis and Forecasts, 2019-2027 36.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 36.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 37. Egypt Textile Reinforced Concrete e Market Analysis and Forecasts, 2019-2027 37.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 37.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 38. Nigeria Expression Vector Market Analysis and Forecasts, 2019-2027 38.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 38.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 39. Rest of ME&A Expression Vector Market Analysis and Forecasts, 2019-2027 39.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 39.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 40. South America Expression Vector Market Analysis and Forecasts, 2019-2027 40.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 40.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 41. South America Expression Vector Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Expression Vector Market Analysis and Forecasts, 2019-2027 42.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 42.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 43. Argentina Expression Vector Market Analysis and Forecasts, 2019-2027 43.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 43.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 44. Rest of South America Expression Vector Market Analysis and Forecasts, 2019-2027 44.1. Market Size (Value) Estimates & Forecast By Types, 2019-2027 44.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Expression Vector Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Natus Medical, Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Promega Corporation 45.3.3. Agilent Technologies 45.3.4. Thermo Fisher Scientific, Inc. 45.3.5. Bio-Rad Laboratories 45.3.6. Merck Millipore 45.3.7. QIAGEN 45.3.8. Clontech Laboratories, Inc. 45.3.9. DNA2.0 45.3.10. New England Biolabs 45.3.11. Sigma-Aldrich Corporation 45.3.12. GenScript USA Inc 46. Primary Key Insights

About This Report

Report ID115976
Category Healthcare
Published DateAug 2021
Updated Date
Contact Us